Ferroptosis biomarkers predict tumor mutation burden's impact on prognosis in HER2-positive breast cancer

doi:10.5306/wjco.v15.i3.391

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2448)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-8) series, Tables (1-2) series.

Item

Count

PDF

HTML

1589

Figures (1-8)

173

Tables (1-2)

216

Sum=2035

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

304

Sum=352

Mar 24, 2024 (publication date) through Dec 23, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Oncol. Mar 24, 2024; 15(3): 391-410
Published online Mar 24, 2024. doi: 10.5306/wjco.v15.i3.391

Full Size Figure Download Figure

Figure 4 Results of univariate and multivariate Cox regression analyses. A: Results of the univariate and multivariate Cox analyses of overall survival (OS) in the TCGA derivation cohort; B: Results of univariate and multivariate Cox analyses of OS in the METABRIC derivation cohort. ^aP < 0.05, ^bP < 0.01, ^cP < 0.001. HR: Hazard ratio.

Citation: Shi JY, Che X, Wen R, Hou SJ, Xi YJ, Feng YQ, Wang LX, Liu SJ, Lv WH, Zhang YF. Ferroptosis biomarkers predict tumor mutation burden's impact on prognosis in HER2-positive breast cancer. World J Clin Oncol 2024; 15(3): 391-410
URL: https://www.wjgnet.com/2218-4333/full/v15/i3/391.htm
DOI: https://dx.doi.org/10.5306/wjco.v15.i3.391